The rapid effects of budesonide plus formoterol in patients with obstructive airway diseases
Open Access
- 1 September 2015
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 9, 5287-90
Abstract
The use of a combination inhaler containing budesonide and formoterol (BUD/FOR) to both maintenance and quick relief therapy has been recommended as an improved method of using inhaled corticosteroid/long-acting β agonist therapy. The aim of this study was to investigate the acute effects of BUD/FOR and testing the availability of BUD/FOR for early reversibility test in patients with airway obstruction. The study was conducted on patients who were admitted to the Department of Pulmonary Medicine, Samsun Medical Park Hospital, Samsun, Turkey. A total of 44 patients were included in the study. The mean age of patients was 48.5 ± 17.3 (range 10-75) years and the male-to-female ratio was 36:8. The pre-bronchodilator pulmonary function test results are as follows: the mean forced vital capacity, 3,025 ± 1,162 mL (76.3% ± 23.2%); mean forced expiratory volume in 1 second (FEV1), 1,898 ± 725 mL (59.2% ± 19.1%); mean FEV1/forced vital capacity, 62.8 ± 6.3% (range 42%-70%); mean peak expiratory flow, 3,859 ± 1,779 mL (48.0% ± 19.7%); and forced expiratory flow 25%-75%, 1,295 ± 486 mL (35.8% ± 12.3%). The reversibility was positive in 26 (59.1%) patients. The absolute change and percentage of change in FEV1 were 318 ± 228 mL and 17.7% ± 11.9%, respectively. The patients were divided into two groups according to reversibility (reversible and irreversible) and both groups were compared with changes according to spirometric results. FEV1 values were statistically different between the two groups. The fixed combination of BUD/FOR has rapid bronchodilator effect, and they can be used for early reversibility test.Keywords
This publication has 6 references indexed in Scilit:
- Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthmaRespirology, 2014
- The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstructionInternational Journal of Chronic Obstructive Pulmonary Disease, 2014
- The effects of long-acting β2-agonists plus inhaled corticosteroids for early reversibility in patients with airway obstruction2013
- Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and childrenCochrane Database of Systematic Reviews, 2013
- Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trialThe Lancet Respiratory Medicine, 2013
- Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma controlBMJ, 2007